You are here

  • Home
  • Archive
  • Volume 76, Issue 11
  • Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis

Article Text

Article menu

This article has been retracted. Please see:

Download PDFPDF

XML
Basic and translational research
Extended report
Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
  1. Paul P Tak1,
  2. Marieke E Doorenspleet2,3,
  3. Maria J H de Hair1,
  4. Paul L Klarenbeek2,3,
  5. Marian H van Beers-Tas4,
  6. Antoine H C van Kampen5,
  7. Dirkjan van Schaardenburg4,
  8. Danielle M Gerlag1,
  9. Frank Baas3,
  10. Niek de Vries2
  1. 1 Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  2. 2 Amsterdam Rheumatology and Immunology Center, Academic Medical Center, Amsterdam, The Netherlands
  3. 3 Department of Genome Analysis, Academic Medical Center, Amsterdam, The Netherlands
  4. 4 Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands
  5. 5 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Niek de Vries, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam 1100 DE, The Netherlands; n.devries{at}amc.uva.nl

Abstract

This article has been retracted

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/annrheumdis-2017-211351

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.